Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid, Acute

Explore clinical trials studying Leukemia, Myeloid, Acute. Study availability and eligibility vary by location and protocol.

134 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid, Acute trial results

Completed

A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia

NCT03416179

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations
  • UCLA Department of Medicine Los Angeles, California, United States
  • UCLA Drug Information/Investigational Drugs Los Angeles, California, United States
  • UCLA Hematology/Oncology Clinic Los Angeles, California, United States
  • UCLA Ronald Reagan Medical Center Los Angeles, California, United States
View all 149 locations
View Trial Details
Completed

An Efficacy and Safety Study of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Adults With Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly Patients With Acute Myeloid Leukemia (AML)

NCT02775903

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • Georgetown University Hospital Washington D.C., District of Columbia, United States
  • University of Florida Gainesville, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 103 locations
View Trial Details
Completed

Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2)

NCT01721876

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations
  • University of California Los Angeles, California, United States
  • St. Luke's Hospital Association of Duluth, Inc. Duluth, Minnesota, United States
  • Henry-Joyce Cancer Clinic Nashville, Tennessee, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View all 122 locations
View Trial Details
Completed

Study of Liposomal Annamycin for the Treatment of Subjects With Acute Myeloid Leukemia (AML)

NCT03388749

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations
  • Medical University of Lodz Lodz, Poland
  • Szpital Kliniczny Przemienienia Pańskiego Uniwersytetu Medycznego im. Karola Marcinkowskiego Poznan, Poland
  • Samodzielny Publiczny Szpital Kliniczny nr 1 im. Prof. Tadeusza Sokołowskiego w Szczecinie, Klinika Hematologii z Oddziałem Transplantacji Szpiku Szczecin, Poland
  • Instytut Hematologii i Transfuzjologii, Klinika Hematologii Warsaw, Poland
View Trial Details
Completed

Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603)

NCT00849147

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +23 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California San Diego Medical Center La Jolla, California, United States
  • University of Florida College of Medicine (Shands) Gainesville, Florida, United States
  • Bone Marrow Transplant Group of Georgia, Northside Hospital Atlanta, Georgia, United States
View all 17 locations
View Trial Details
Completed

Evaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant (BMT CTN 0604)

NCT00864227

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +23 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of Florida College of Medicine, Shands Gainesville, Florida, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
View all 16 locations
View Trial Details
Completed

An Efficacy and Safety Study of Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine in Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML) and Low-Blast Acute Myelogenous Leukemia (AML)

NCT02610777

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +12 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Greenville Health System Little Rock, Arkansas, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Compassionate Cancer Care Medical Group Incorporated Riverside, California, United States
View all 59 locations
View Trial Details

Related conditions